Cargando…
Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy
Eukaryotic elongation factor 2 kinase (eEF2K) inhibits the elongation stage of protein synthesis by phosphorylating its only known substrate, eEF2. eEF2K is tightly regulated by nutrient-sensitive signalling pathways. For example, it is inhibited by signalling through mammalian target of rapamycin c...
Autores principales: | Moore, Claire E.J., Wang, Xuemin, Xie, Jianling, Pickford, Jo, Barron, John, Regufe da Mota, Sergio, Versele, Matthias, Proud, Christopher G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760274/ https://www.ncbi.nlm.nih.gov/pubmed/26795954 http://dx.doi.org/10.1016/j.cellsig.2016.01.005 |
Ejemplares similares
-
Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer
por: Wang, Xuemin, et al.
Publicado: (2017) -
Eukaryotic elongation factor 2 kinase regulates the synthesis of microtubule‐related proteins in neurons
por: Kenney, Justin W., et al.
Publicado: (2015) -
Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase
por: Pyr Dit Ruys, Sébastien, et al.
Publicado: (2012) -
Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains
por: Pigott, Craig R., et al.
Publicado: (2012) -
mTOR inhibitors in cancer therapy
por: Xie, Jianling, et al.
Publicado: (2016)